PHOSPHATE SANDOZ Effervescent Tablets: Benefits and Key Features

Benefits of PHOSPHATE SANDOZ Effervescent Tablets

• Treatment of hypercalcaemia associated with conditions such as hyperparathyroidism, multiple myelomatosis, and malignancy
• Treatment of hypophosphataemia associated with vitamin D resistant rickets and vitamin D resistant hypophosphataemic osteomalacia

Key Features of PHOSPHATE SANDOZ Effervescent Tablets

• Easy to administer: dissolve in 1/3 to 1/2 a tumblerful of water and take orally
• Adjustable dosage to suit individual patient requirements
• Available in tablet form for convenient administration

Dosage and Administration of PHOSPHATE SANDOZ Effervescent Tablets

PHOSPHATE SANDOZ Effervescent Tablets should be taken orally, dissolved in 1/3 to 1/2 a tumblerful of water. The dosage should be adjusted to suit the requirements of individual patients.

Adults

• Hypercalcaemia: up to 6 tablets daily (adjustment being made according to requirements)
• Vitamin D resistant hypophosphateaemic osteomalacia: 4-6 tablets daily

Children under 5 years

• Hypercalcaemia: up to 3 tablets daily (adjustment being made according to requirements)
• Vitamin D resistant rickets: 2-3 tablets daily

Special Considerations for PHOSPHATE SANDOZ Effervescent Tablets

• Particular care should be taken to ensure appropriate dosage in the elderly, as excessive dosage has been reported to produce hypocalcaemia in isolated cases.
• In cases of impaired renal function associated with hypercalcaemia, and in cases where restricted sodium intake is required (e.g., congestive cardiac failure, hypertension, or pre-eclamptic toxaemia), the sodium (20.4mmol per tablet) and potassium (3.1mmol per tablet) content of PHOSPHATE SANDOZ should be taken into consideration.
• Close monitoring of serum levels is recommended in cases of hypercalcaemia associated with impaired renal function and hyperphosphataemia.
• Careful surveillance of patients is recommended, especially if on long-term therapy, due to the risk of soft tissue calcification and nephrocalcinosis.